Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Upfront operable primary breast tumor measuring upto and including 5cm in maximum tumor dimension with clinically lymph node negative breast cancers (Tis, T1,T2-N0) 2. Consenting patient
Exclusion criteria
Exclusion criteria: 1. With T3, T4 lesions 2. Who are Pregnant, Lactating 3. Patients with history of previous radiotherapy to the breast or axilla 4. Patients with history of previous surgery of Axilla or chest wall 5. Patients who have received Neo-adjuvant chemotherapy 6. H/o hypersensitivity to any of the agents used 7. Not giving consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Detection proportion among both groups-Proportion of number of sentinel lymph nodes identified in each group Timepoint: 25/01/2020 to 30/11/2021 | — |
Secondary
| Measure | Time frame |
|---|---|
| - Cost calculation and procedure time of doing SLNB in each groupTimepoint: 25/01/2020 to 30/11/2021 | — |
Countries
India
Contacts
All India Institute of Medical Sciences